Fujian Shengdi Pharmaceutical Co., Ltd.

This early-stage study is testing two different versions of an experimental tablet called HRS9531 for weight management. It will involve 168 overweight or obese men to see how their bodies process each version and to check for side effects. The main goal is to compare the two tab…

This study is testing whether a new injectable drug called HRS-5635, given alone or with other medications, can help control chronic hepatitis B. It will involve 369 adults who already have the virus under control with standard pills. Researchers will check if the new treatment c…

This study is testing whether a new injectable medication called HRS9531 can help people who have both obesity and obstructive sleep apnea. The trial will involve 140 adults who are already using a CPAP machine for their sleep apnea. Researchers will measure if the injection redu…

This study aims to see if a new drug called HRS9531 works better than a placebo (inactive substance) at lowering blood sugar in adults with type 2 diabetes. It is for people whose blood sugar is still not well controlled even while taking a long-acting insulin. About 300 particip…

This study is testing whether a new drug called HRS-9563 can safely lower blood pressure in people with mild to moderate high blood pressure. About 234 adults will receive either the drug or a placebo for 9 months, and researchers will measure their blood pressure regularly. The …

This is an early-stage study to test the safety of a new injection called HRS-2162. The drug is designed to help patients regain muscle control after surgery when they are given paralyzing anesthesia. The study will enroll 64 healthy volunteers to see how their bodies handle a si…

This study is testing an investigational injection called HRS9531 for adults with both obstructive sleep apnea and obesity who are not using a CPAP machine. Over 52 weeks, researchers will measure if the treatment improves nighttime breathing events, reduces daytime sleepiness, a…

This study is testing whether a new injection called HRS-7450 can help people recover better after a recent ischemic stroke. It will involve 208 adults who had stroke symptoms start between 4.5 and 24 hours ago. Participants are randomly assigned to receive either the real inject…

This study is testing two new drugs, HRS-7249 and SHR-1918, to see if they can safely lower very high levels of triglycerides (a type of fat in the blood) in adults. The main goal is to see if lowering these fats reduces the risk of a sudden, painful condition called acute pancre…

This is a very early-stage study to check the safety and how the body processes a new injectable drug called HRS-5817. It will involve 92 healthy adult volunteers, some with obesity and some without. The main goal is to see how safe the drug is and how it behaves in the body when…

This study is testing whether an experimental injection called HRS-9057 can safely reduce dangerous fluid buildup in people hospitalized for heart failure. Researchers will compare it to a placebo (dummy injection) in about 118 participants to see if it helps patients lose excess…

This study is testing an experimental drug called HRS-7249 to see if it safely lowers high levels of triglycerides, a type of fat in the blood. It will involve about 200 adults with high cholesterol, comparing the drug against a placebo. The main goal is to find the right dose an…